selegiline has been researched along with quinolinic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Behan, WM; Darlington, LG; McDonald, M; Stone, TW | 1 |
| Cano, J; de Pablos, RM; Herrera, AJ; Machado, A; Tomás-Camardiel, M | 1 |
2 other study(ies) available for selegiline and quinolinic acid
| Article | Year |
|---|---|
Oxidative stress as a mechanism for quinolinic acid-induced hippocampal damage: protection by melatonin and deprenyl.
Topics: Animals; Antioxidants; Hippocampus; Lipid Peroxidation; Male; Melatonin; Neuroprotective Agents; Oxidative Stress; Quinolinic Acid; Rats; Rats, Wistar; Selegiline | 1999 |
Deprenyl enhances the striatal neuronal damage produced by quinolinic acid.
Topics: Animals; Antiparkinson Agents; Biomarkers; Calbindins; Corpus Striatum; Dopamine; Female; gamma-Aminobutyric Acid; Glutamate Decarboxylase; In Situ Hybridization; Isoenzymes; Neurons; Oxidopamine; Parvalbumins; Quinolinic Acid; Rats; Rats, Wistar; Receptors, Dopamine D2; S100 Calcium Binding Protein G; Selegiline; Sympatholytics; Tyrosine 3-Monooxygenase | 2005 |